US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 res

FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences,

FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading

US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market.

At CYTO 2026, Cytek will showcase its cell analysis solutions, including the public debut of a new 7

US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixe

Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth

Stephens & Co. analyst Mason Carrico maintains Cytek Biosciences (NASDAQ:CTKB) with a Overwei

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.12 per share versus the Zacks Co

Cytek Biosciences (NASDAQ:CTKB) affirms FY2026 sales outlook from $205.000 million-$212.000 million

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.15) per share which missed the anal

FREMONT, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “C

Cytek Biosciences, Inc. (NASDAQ: CTKB - Get Free Report) has been assigned an average recommendation

FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or

Cytek Biosciences celebrates one year of operations at its Singapore facility, which has enhanced Cy

Cytek Biosciences (NASDAQ: CTKB) outlined its recent product launches, geographic diversification, a

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Co

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences (NASDAQ:CTKB) sees FY2026 sales of $205.000 million-$212.000 million vs $207.058 m

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.34) per share which missed the anal

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or

FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading

FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company to present at the 44th Annual JP Morgan Healthcare Conference Company to present at the 44th

Cytek Biosciences, Inc. (NASDAQ: CTKB - Get Free Report) has received a consensus recommendation of

Bank of Montreal Can raised its holdings in Cytek Biosciences, Inc. (NASDAQ: CTKB) by 110.7% during

Cytek Biosciences offers a full-spectrum cytometry platform. This means they provide instruments, re

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

  On Wednesday, 311 stocks hit new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

  Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn

  On Friday, 1043 companies hit new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  On Friday, 431 companies hit new 52-week lows.

  On Thursday, 112 stocks made new 52-week lows.

    Tuesday's session saw 729 companies set new 52-week lows.